rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
55
|
pubmed:dateCreated |
2004-3-11
|
pubmed:abstractText |
The aim of the study was to evaluate if measurement of TGF-beta1 has clinical usefulness as a marker of liver fibrosis using ROC analysis and to assess its serum concentration during IFN alpha treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15011870-Adolescent,
pubmed-meshheading:15011870-Child,
pubmed-meshheading:15011870-Child, Preschool,
pubmed-meshheading:15011870-Female,
pubmed-meshheading:15011870-Hepatitis B, Chronic,
pubmed-meshheading:15011870-Humans,
pubmed-meshheading:15011870-Immunoenzyme Techniques,
pubmed-meshheading:15011870-Interferon-alpha,
pubmed-meshheading:15011870-Liver,
pubmed-meshheading:15011870-Liver Cirrhosis,
pubmed-meshheading:15011870-Male,
pubmed-meshheading:15011870-Predictive Value of Tests,
pubmed-meshheading:15011870-ROC Curve,
pubmed-meshheading:15011870-Transforming Growth Factor beta,
pubmed-meshheading:15011870-Transforming Growth Factor beta1
|
pubmed:articleTitle |
Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
|
pubmed:affiliation |
IIIrd Department of Pediatrics, Medical University of Bialystok, Poland. DariuszMar.8810735@pharmanet.com.pl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|